Patricia Nez Henderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patricia Nez Henderson has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Raglan Maddox
Yardhura Walani, National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia
7 shared publications - Jonathan B. Bricker
Division of Public Health Sciences, Fred Hutch Cancer Center, Seattle, WA, United States
5 shared publications - Margarita Santiago-Torres
Fred Hutchinson Cancer Center, Seattle, WA, United States
5 shared publications - Brianna M. Sullivan
Fred Hutchinson Cancer Center, Seattle, WA, United States
4 shared publications - Chase Kornacki
IndigeQuit Community Advisory Board, Cancer Consortium, Seattle, WA, United States
4 shared publications - Crystal M. Stanford
IndigeQuit Community Advisory Board, Cancer Consortium, Seattle, WA, United States
4 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e102675
A Culturally Adapted Smoking Cessation App (IndigeQuit) for American Indian and Alaska Native Adults: Protocol for a Randomized Clinical Trial
Background: Due to limited access to evidence-based cessation support, American Indian and Alaska Native (AI/AN) adults are half as likely to quit commercial cigarette smoking as other racial and ethnic groups. Geographical barriers, underfunded health systems, and limited integration of cessation services into routine care have reduced access to effective treatment in AI/AN communities. These challenges are compounded by a lack of culturally relevant interventions tailored to AI/AN adults. Thus, there is an urgent need for accessible, scalable, and culturally relevant interventions. Objective: Here, we describe the protocol for a randomized clinical trial (RCT) testing the efficacy of a culturally adapted smoking cessation app (IndigeQuit) developed specifically to help AI/AN adults quit smoking commercial cigarettes compared to a standard, nontailored app (QuitGuide). Methods: To improve the relevance and acceptability of cessation support to AI/AN adults, IndigeQuit was developed through a cultural adaptation of iCanQuit, an evidence-based smartphone app grounded in acceptance and commitment therapy that teaches skills for accepting cravings to smoke. The cultural adaptation used a user-centered, community-based participatory research mixed methods approach in collaboration with a community advisory board (CAB) comprising AI/AN individuals. Cultural adaptations included the use of Native imagery; stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community; and the important distinction between ceremonial and commercial tobacco. A total of 776 AI/AN adults who smoke and want to quit are being recruited nationwide and randomized to receive IndigeQuit or QuitGuide for 12 months. The primary aim of the RCT is to determine the efficacy of IndigeQuit compared with QuitGuide for 30-day abstinence at 12 months. Secondary aims include abstinence at earlier time points, identifying mediators and moderators of treatment effects, and assessing engagement and satisfaction. Qualitative interviews with IndigeQuit participants and CAB members will inform the development of a subsequent guide to support the broad dissemination of IndigeQuit nationwide. Results: The National Cancer Institute funded this study in 2024 (grant R01 CA284687), with the grant awarded to the principal investigator, JBB. As of August 2026, a total of 590 AI/AN adults had been enrolled in the trial. Data collection started in July 2025 and is expected to be completed by November 2028. Conclusions: The IndigeQuit app was designed to deliver evidence-based smoking cessation treatment that is culturally adapted to AI/AN communities and grounded in acceptance and commitment therapy. If effective, this intervention could offer a more scalable and culturally relevant treatment to AI/AN communities nationwide, helping to reduce smoking-related health inequities. Trial Registration: ClinicalTrials.gov NCT06145763; https://clinicaltrials.gov/study/NCT06145763 International Registered Report Identifier (IRRID): DERR1-10.2196/102675
- 2 September 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e102675
Open AccessA Culturally Adapted Smoking Cessation App (IndigeQuit) for American Indian and Alaska Native Adults: Protocol for a Randomized Clinical Trial
Background: Due to limited access to evidence-based cessation support, American Indian and Alaska Native (AI/AN) adults are half as likely to quit commercial cigarette smoking as other racial and ethnic groups. Geographical barriers, underfunded health systems, and limited integration of cessation services into routine care have reduced access to effective treatment in AI/AN communities. These challenges are compounded by a lack of culturally relevant interventions tailored to AI/AN adults. Thus, there is an urgent need for accessible, scalable, and culturally relevant interventions. Objective: Here, we describe the protocol for a randomized clinical trial (RCT) testing the efficacy of a culturally adapted smoking cessation app (IndigeQuit) developed specifically to help AI/AN adults quit smoking commercial cigarettes compared to a standard, nontailored app (QuitGuide). Methods: To improve the relevance and acceptability of cessation support to AI/AN adults, IndigeQuit was developed through a cultural adaptation of iCanQuit, an evidence-based smartphone app grounded in acceptance and commitment therapy that teaches skills for accepting cravings to smoke. The cultural adaptation used a user-centered, community-based participatory research mixed methods approach in collaboration with a community advisory board (CAB) comprising AI/AN individuals. Cultural adaptations included the use of Native imagery; stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community; and the important distinction between ceremonial and commercial tobacco. A total of 776 AI/AN adults who smoke and want to quit are being recruited nationwide and randomized to receive IndigeQuit or QuitGuide for 12 months. The primary aim of the RCT is to determine the efficacy of IndigeQuit compared with QuitGuide for 30-day abstinence at 12 months. Secondary aims include abstinence at earlier time points, identifying mediators and moderators of treatment effects, and assessing engagement and satisfaction. Qualitative interviews with IndigeQuit participants and CAB members will inform the development of a subsequent guide to support the broad dissemination of IndigeQuit nationwide. Results: The National Cancer Institute funded this study in 2024 (grant R01 CA284687), with the grant awarded to the principal investigator, JBB. As of August 2026, a total of 590 AI/AN adults had been enrolled in the trial. Data collection started in July 2025 and is expected to be completed by November 2028. Conclusions: The IndigeQuit app was designed to deliver evidence-based smoking cessation treatment that is culturally adapted to AI/AN communities and grounded in acceptance and commitment therapy. If effective, this intervention could offer a more scalable and culturally relevant treatment to AI/AN communities nationwide, helping to reduce smoking-related health inequities. Trial Registration: ClinicalTrials.gov NCT06145763; https://clinicaltrials.gov/study/NCT06145763 International Registered Report Identifier (IRRID): DERR1-10.2196/102675
- Open Access
- 27 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
IndigeQuit: Protocol for a Randomized Clinical Trial of a Culturally Adapted Smoking Cessation App for American Indian and Alaska Native Adults (Preprint)
BACKGROUND Gaps in access to effective, culturally relevant cessation support among American Indian and Alaska Native (AI/AN) communities have contributed to poor cessation outcomes, and consequently, to smoking-related health inequities. OBJECTIVE Here we describe the protocol for a randomized clinical trial (RCT) that is testing the efficacy of a culturally adapted smoking cessation app (IndigeQuit) developed specifically to help AI/AN adults quit commercial cigarette smoking relative to a standard, non-tailored app (QuitGuide). METHODS To improve the relevance and acceptability of cessation support to AI/AN adults, IndigeQuit was developed through a cultural adaptation of iCanQuit, an evidence-based smartphone application grounded in acceptance and commitment therapy that teaches skills for accepting cravings to smoke. The cultural adaptation followed a community-based participatory research mixed methods approach with a Community Advisory Board (CAB) of AI/AN individuals. Cultural adaptations included the use of Native imagery, stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community, and the important distinction between ceremonial and commercial tobacco. A total of 776 AI/AN adults who smoke and want to quit are being recruited nationwide and randomized to receive IndigeQuit or QuitGuide for 12 months. The primary aim of the RCT is to determine the efficacy of IndigeQuit vs QuitGuide for 30-day abstinence at 12 months. Secondary aims include abstinence at earlier timepoints, identifying mediators and moderators of treatment effects, and assessing engagement and satisfaction. Qualitative interviews with IndigeQuit participants and CAB members will inform the development of a subsequent guide to support the broad dissemination of IndigeQuit nationwide. RESULTS The National Institute of Cancer funded this study in 2024 (R01 CA284687, Principal Investigator, JBB). As of May 2026, 353 AI/AN adults had been enrolled in the trial. Enrollment is expected to be completed by November 2028. CONCLUSIONS The IndigeQuit app was designed to deliver evidence-based smoking cessation treatment that is culturally adapted to AI/AN and grounded in Acceptance and Commitment Therapy. If effective, this intervention could offer a more scalable and culturally relevant treatment to AI/AN communities nationwide, helping to reduce smoking-related health inequities. CLINICALTRIAL ClinicalTrials.gov Identifier, NCT06145763; https://clinicaltrials.gov/study/NCT06145763
- 27 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIndigeQuit: Protocol for a Randomized Clinical Trial of a Culturally Adapted Smoking Cessation App for American Indian and Alaska Native Adults (Preprint)
BACKGROUND Gaps in access to effective, culturally relevant cessation support among American Indian and Alaska Native (AI/AN) communities have contributed to poor cessation outcomes, and consequently, to smoking-related health inequities. OBJECTIVE Here we describe the protocol for a randomized clinical trial (RCT) that is testing the efficacy of a culturally adapted smoking cessation app (IndigeQuit) developed specifically to help AI/AN adults quit commercial cigarette smoking relative to a standard, non-tailored app (QuitGuide). METHODS To improve the relevance and acceptability of cessation support to AI/AN adults, IndigeQuit was developed through a cultural adaptation of iCanQuit, an evidence-based smartphone application grounded in acceptance and commitment therapy that teaches skills for accepting cravings to smoke. The cultural adaptation followed a community-based participatory research mixed methods approach with a Community Advisory Board (CAB) of AI/AN individuals. Cultural adaptations included the use of Native imagery, stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community, and the important distinction between ceremonial and commercial tobacco. A total of 776 AI/AN adults who smoke and want to quit are being recruited nationwide and randomized to receive IndigeQuit or QuitGuide for 12 months. The primary aim of the RCT is to determine the efficacy of IndigeQuit vs QuitGuide for 30-day abstinence at 12 months. Secondary aims include abstinence at earlier timepoints, identifying mediators and moderators of treatment effects, and assessing engagement and satisfaction. Qualitative interviews with IndigeQuit participants and CAB members will inform the development of a subsequent guide to support the broad dissemination of IndigeQuit nationwide. RESULTS The National Institute of Cancer funded this study in 2024 (R01 CA284687, Principal Investigator, JBB). As of May 2026, 353 AI/AN adults had been enrolled in the trial. Enrollment is expected to be completed by November 2028. CONCLUSIONS The IndigeQuit app was designed to deliver evidence-based smoking cessation treatment that is culturally adapted to AI/AN and grounded in Acceptance and Commitment Therapy. If effective, this intervention could offer a more scalable and culturally relevant treatment to AI/AN communities nationwide, helping to reduce smoking-related health inequities. CLINICALTRIAL ClinicalTrials.gov Identifier, NCT06145763; https://clinicaltrials.gov/study/NCT06145763
- Open Access
- 24 March 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e88768
Development of a Culturally Adapted Smartphone App (IndigeQuit) Designed to Help American Indian and Alaska Native People Quit Commercial Cigarettes: User-Centered Mixed Methods Study
Background: Due to the colonization of tobacco plants by European settlers and the subsequent intensive marketing of commercial tobacco products to American Indian and Alaska Native (AI/AN) communities in the United States, commercial cigarette smoking accounts for half of all deaths among AI/AN people. Limited awareness, access to treatment, and the absence of culturally relevant, effective smoking cessation interventions contribute to these high death rates. Objective: This study aims to culturally adapt iCanQuit, a smartphone smoking cessation app proven efficacious for the general population, for AI/AN people. Methods: A user-centered and community-based participatory research (CBPR) mixed methods approach was applied to culturally adapt iCanQuit for AI/AN people in collaboration with a community advisory board (CAB) of AI/AN individuals using a 3-step process. Step 1 identified ways to culturally adapt the iCanQuit for AI/AN people through 1-on-1 qualitative interviews with 8 prior iCanQuit AI/AN participants. Step 2 involved developing prototypes of cultural refinements identified in step 1 through regular biweekly meetings of the CAB, research, and app development teams. The prototypes were then evaluated with a separate group of 4 prior iCanQuit AI/AN participants through 1-on-1 qualitative interviews. Step 3 involved beta testing the app through a 6-day diary study followed by 1-on-1 qualitative interviews with a nationally recruited group of 7 AI/AN adults who smoke commercial cigarettes. The development work associated with step 3 was further informed by the CAB and the research and app development teams. Results: Key findings identified 5 cultural refinements that informed subsequent app development and testing: (1) stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community; (2) honoring the Earth as a motivator for cessation; (3) a guide character representative of AI/AN people; (4) clear distinction between ceremonial and commercial tobacco use; and (5) use of earth tones in visual design. In Step 3, all 7 (100%) diary study participants rated the beta version of the app as excellent or good/meets expectations (5/7, 71%, and 2/7, 29%, respectively) and that it felt made for them. They suggested 6 modifications which were incorporated into the final version of the app: (1) include vaping frequently asked questions, (2) feature motivation icons more prominently, (3) increase notification frequency, (4) track today’s cigarettes rather than yesterday’s, (5) allow users to update how much they spend per pack of cigarettes; and (6) rename the medications tool to reflect the inclusion of AI/AN traditional healing modalities. Conclusions: A user-centered and CBPR development process yielded IndigeQuit—one of the first known apps developed specifically to help AI/AN adults quit commercial cigarette smoking. Trial Registration: ClinicalTrials.gov NCT06145763; https://clinicaltrials.gov/ct2/show/NCT06145763
- 24 March 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e88768
Open AccessDevelopment of a Culturally Adapted Smartphone App (IndigeQuit) Designed to Help American Indian and Alaska Native People Quit Commercial Cigarettes: User-Centered Mixed Methods Study
Background: Due to the colonization of tobacco plants by European settlers and the subsequent intensive marketing of commercial tobacco products to American Indian and Alaska Native (AI/AN) communities in the United States, commercial cigarette smoking accounts for half of all deaths among AI/AN people. Limited awareness, access to treatment, and the absence of culturally relevant, effective smoking cessation interventions contribute to these high death rates. Objective: This study aims to culturally adapt iCanQuit, a smartphone smoking cessation app proven efficacious for the general population, for AI/AN people. Methods: A user-centered and community-based participatory research (CBPR) mixed methods approach was applied to culturally adapt iCanQuit for AI/AN people in collaboration with a community advisory board (CAB) of AI/AN individuals using a 3-step process. Step 1 identified ways to culturally adapt the iCanQuit for AI/AN people through 1-on-1 qualitative interviews with 8 prior iCanQuit AI/AN participants. Step 2 involved developing prototypes of cultural refinements identified in step 1 through regular biweekly meetings of the CAB, research, and app development teams. The prototypes were then evaluated with a separate group of 4 prior iCanQuit AI/AN participants through 1-on-1 qualitative interviews. Step 3 involved beta testing the app through a 6-day diary study followed by 1-on-1 qualitative interviews with a nationally recruited group of 7 AI/AN adults who smoke commercial cigarettes. The development work associated with step 3 was further informed by the CAB and the research and app development teams. Results: Key findings identified 5 cultural refinements that informed subsequent app development and testing: (1) stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community; (2) honoring the Earth as a motivator for cessation; (3) a guide character representative of AI/AN people; (4) clear distinction between ceremonial and commercial tobacco use; and (5) use of earth tones in visual design. In Step 3, all 7 (100%) diary study participants rated the beta version of the app as excellent or good/meets expectations (5/7, 71%, and 2/7, 29%, respectively) and that it felt made for them. They suggested 6 modifications which were incorporated into the final version of the app: (1) include vaping frequently asked questions, (2) feature motivation icons more prominently, (3) increase notification frequency, (4) track today’s cigarettes rather than yesterday’s, (5) allow users to update how much they spend per pack of cigarettes; and (6) rename the medications tool to reflect the inclusion of AI/AN traditional healing modalities. Conclusions: A user-centered and CBPR development process yielded IndigeQuit—one of the first known apps developed specifically to help AI/AN adults quit commercial cigarette smoking. Trial Registration: ClinicalTrials.gov NCT06145763; https://clinicaltrials.gov/ct2/show/NCT06145763
- Open Access
- 9 March 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (8) , 1461-1466
Defining the commercial tobacco industry in a changing nicotine landscape
Raglan Maddox, Patricia Nez Henderson, Lani Teddy, Sydney A Martinez, Josephine T Hinds, Michelle Kennedy, Mignonne C Guy; Defining the commercial Tobacco
- 9 March 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (8) , 1461-1466
Open AccessDefining the commercial tobacco industry in a changing nicotine landscape
Raglan Maddox, Patricia Nez Henderson, Lani Teddy, Sydney A Martinez, Josephine T Hinds, Michelle Kennedy, Mignonne C Guy; Defining the commercial Tobacco
- Open Access
- 1 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Development of a Culturally Adapted Smartphone App (IndigeQuit) Designed to Help American Indian and Alaska Native People Quit Commercial Cigarettes: User-Centered Mixed Methods Study (Preprint)
BACKGROUND Due to the colonization of tobacco plants by European settlers and the subsequent intensive marketing of commercial tobacco products to American Indian and Alaska Native (AI/AN) communities in the United States, commercial cigarette smoking accounts for half of all deaths among AI/AN people. Limited awareness, access to treatment, and the absence of culturally relevant, effective smoking cessation interventions contribute to these high death rates. OBJECTIVE This study aims to culturally adapt iCanQuit, a smartphone smoking cessation app proven efficacious for the general population, for AI/AN people. METHODS A user-centered and community-based participatory research (CBPR) mixed methods approach was applied to culturally adapt iCanQuit for AI/AN people in collaboration with a community advisory board (CAB) of AI/AN individuals using a 3-step process. Step 1 identified ways to culturally adapt the iCanQuit for AI/AN people through 1-on-1 qualitative interviews with 8 prior iCanQuit AI/AN participants. Step 2 involved developing prototypes of cultural refinements identified in step 1 through regular biweekly meetings of the CAB, research, and app development teams. The prototypes were then evaluated with a separate group of 4 prior iCanQuit AI/AN participants through 1-on-1 qualitative interviews. Step 3 involved beta testing the app through a 6-day diary study followed by 1-on-1 qualitative interviews with a nationally recruited group of 7 AI/AN adults who smoke commercial cigarettes. The development work associated with step 3 was further informed by the CAB and the research and app development teams. RESULTS Key findings identified 5 cultural refinements that informed subsequent app development and testing: (1) stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community; (2) honoring the Earth as a motivator for cessation; (3) a guide character representative of AI/AN people; (4) clear distinction between ceremonial and commercial tobacco use; and (5) use of earth tones in visual design. In Step 3, all 7 (100%) diary study participants rated the beta version of the app as excellent or good/meets expectations (5/7, 71%, and 2/7, 29%, respectively) and that it felt made for them. They suggested 6 modifications which were incorporated into the final version of the app: (1) include vaping frequently asked questions, (2) feature motivation icons more prominently, (3) increase notification frequency, (4) track today’s cigarettes rather than yesterday’s, (5) allow users to update how much they spend per pack of cigarettes; and (6) rename the medications tool to reflect the inclusion of AI/AN traditional healing modalities. CONCLUSIONS A user-centered and CBPR development process yielded IndigeQuit—one of the first known apps developed specifically to help AI/AN adults quit commercial cigarette smoking. CLINICALTRIAL ClinicalTrials.gov NCT06145763; https://clinicaltrials.gov/ct2/show/NCT06145763
- 1 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDevelopment of a Culturally Adapted Smartphone App (IndigeQuit) Designed to Help American Indian and Alaska Native People Quit Commercial Cigarettes: User-Centered Mixed Methods Study (Preprint)
BACKGROUND Due to the colonization of tobacco plants by European settlers and the subsequent intensive marketing of commercial tobacco products to American Indian and Alaska Native (AI/AN) communities in the United States, commercial cigarette smoking accounts for half of all deaths among AI/AN people. Limited awareness, access to treatment, and the absence of culturally relevant, effective smoking cessation interventions contribute to these high death rates. OBJECTIVE This study aims to culturally adapt iCanQuit, a smartphone smoking cessation app proven efficacious for the general population, for AI/AN people. METHODS A user-centered and community-based participatory research (CBPR) mixed methods approach was applied to culturally adapt iCanQuit for AI/AN people in collaboration with a community advisory board (CAB) of AI/AN individuals using a 3-step process. Step 1 identified ways to culturally adapt the iCanQuit for AI/AN people through 1-on-1 qualitative interviews with 8 prior iCanQuit AI/AN participants. Step 2 involved developing prototypes of cultural refinements identified in step 1 through regular biweekly meetings of the CAB, research, and app development teams. The prototypes were then evaluated with a separate group of 4 prior iCanQuit AI/AN participants through 1-on-1 qualitative interviews. Step 3 involved beta testing the app through a 6-day diary study followed by 1-on-1 qualitative interviews with a nationally recruited group of 7 AI/AN adults who smoke commercial cigarettes. The development work associated with step 3 was further informed by the CAB and the research and app development teams. RESULTS Key findings identified 5 cultural refinements that informed subsequent app development and testing: (1) stories featuring AI/AN adults and elders emphasizing culture, spirituality, family, and community; (2) honoring the Earth as a motivator for cessation; (3) a guide character representative of AI/AN people; (4) clear distinction between ceremonial and commercial tobacco use; and (5) use of earth tones in visual design. In Step 3, all 7 (100%) diary study participants rated the beta version of the app as excellent or good/meets expectations (5/7, 71%, and 2/7, 29%, respectively) and that it felt made for them. They suggested 6 modifications which were incorporated into the final version of the app: (1) include vaping frequently asked questions, (2) feature motivation icons more prominently, (3) increase notification frequency, (4) track today’s cigarettes rather than yesterday’s, (5) allow users to update how much they spend per pack of cigarettes; and (6) rename the medications tool to reflect the inclusion of AI/AN traditional healing modalities. CONCLUSIONS A user-centered and CBPR development process yielded IndigeQuit—one of the first known apps developed specifically to help AI/AN adults quit commercial cigarette smoking. CLINICALTRIAL ClinicalTrials.gov NCT06145763; https://clinicaltrials.gov/ct2/show/NCT06145763
- Open Access
- 8 October 2025
- Published by BMJ in Tobacco Control
Winds of change: a stocktake on progressing the Framework Convention on Tobacco Control in Indigenous contexts
Background The WHO’s Framework Convention on Tobacco Control (FCTC) obligates Parties to reduce tobacco use among Indigenous populations, who suffer disproportionate harm from historical and ongoing colonisation. These obligations must be upheld despite challenges like COVID and the tobacco industry’s influence. Aim and objectives This review updates an earlier analysis of the FCTC reports from Australia, Canada and Aotearoa New Zealand, evaluating their progress in fulfilling obligations to Indigenous peoples between 2018 and 2023. Data sources This study employed a qualitative content analysis to review the FCTC progress reports from Australia, Canada and New Zealand, covering the period from 2018 to 2023. The analysis was based on three Global progress reports and nine country-specific reports. Study selection and data extraction Using consistent search terms aligned with a previous review, we systematically identified relevant activities, achievements and practices reported in the FCTC documents. Two independent reviewers conducted the coding and analysis, and after initial coding, the findings were cross-checked by the research team. Results Across the three countries, there was a focus on increasing Indigenous leadership in the development and implementation of tobacco control programmes. For example, in Australia, the Tackling Indigenous Smoking programme focuses on codesigning culturally tailored interventions to address high smoking rates and overcome challenges, particularly in remote communities, while addressing gaps in providing culturally safe supports. Indigenous leadership in tobacco control was also indicated in New Zealand’s Smokefree Aotearoa 2025 Action Plan and in Canada’s Tobacco Strategy. However, despite the encouraging progress, absence of Indigenous-specific data and inconsistent reporting is challenging, and more work is required.
- 8 October 2025
- Published by BMJ in Tobacco Control
Open AccessWinds of change: a stocktake on progressing the Framework Convention on Tobacco Control in Indigenous contexts
Background The WHO’s Framework Convention on Tobacco Control (FCTC) obligates Parties to reduce tobacco use among Indigenous populations, who suffer disproportionate harm from historical and ongoing colonisation. These obligations must be upheld despite challenges like COVID and the tobacco industry’s influence. Aim and objectives This review updates an earlier analysis of the FCTC reports from Australia, Canada and Aotearoa New Zealand, evaluating their progress in fulfilling obligations to Indigenous peoples between 2018 and 2023. Data sources This study employed a qualitative content analysis to review the FCTC progress reports from Australia, Canada and New Zealand, covering the period from 2018 to 2023. The analysis was based on three Global progress reports and nine country-specific reports. Study selection and data extraction Using consistent search terms aligned with a previous review, we systematically identified relevant activities, achievements and practices reported in the FCTC documents. Two independent reviewers conducted the coding and analysis, and after initial coding, the findings were cross-checked by the research team. Results Across the three countries, there was a focus on increasing Indigenous leadership in the development and implementation of tobacco control programmes. For example, in Australia, the Tackling Indigenous Smoking programme focuses on codesigning culturally tailored interventions to address high smoking rates and overcome challenges, particularly in remote communities, while addressing gaps in providing culturally safe supports. Indigenous leadership in tobacco control was also indicated in New Zealand’s Smokefree Aotearoa 2025 Action Plan and in Canada’s Tobacco Strategy. However, despite the encouraging progress, absence of Indigenous-specific data and inconsistent reporting is challenging, and more work is required.
- 1 August 2025
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 2025 (70) , 184-186
Commercial tobacco, ceremonial tobacco and impact on indigenous people: a land acknowledgment
- 1 August 2025
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 2025 (70) , 184-186
Commercial tobacco, ceremonial tobacco and impact on indigenous people: a land acknowledgment
- Open Access
- 1 July 2025
- Published by Oxford University Press (OUP) in Health Promotion International
- Vol. 40 (4)
Colonial harm in new packaging: Indigenous critiques of the tobacco industry's ‘harm reduction’ rhetoric
Over the last 75 years, we have learned that commercial tobacco use causes widespread disease and death. However, the commercial Tobacco and Nicotine Industry continues to promote, market, and sell tobacco and nicotine products to protect and expand profit. This reflects their legal obligation to act in shareholders’ best interests. While the Tobacco and Nicotine Industry heavily promotes alternative products such as electronic cigarettes and nicotine pouches, for now, these represent a relatively small share of profits compared with combustible cigarette sales. The continued reliance on and expansion of these markets generates addiction, dependence, and a range of harms. These actions represent a modern manifestation of colonization—reproducing control and exploitation that affects people at all levels, particularly Indigenous peoples, whose lands, knowledges, and well-being have long been commodified and targeted. The Tobacco and Nicotine Industry and their collaborators employ misleading strategies, including co-opting terms like ‘harm reduction’ and making vague promises about a ‘smoke-free’ or ‘noncombustible’ future. These tactics distract from the continued promotion and sale of harmful products under the guise of public health and harm reduction. This narrative reframes structural and commercial determinants of health as matters of individual choice and enables the continued production of Tobacco and Nicotine Industry–driven harms. Everyone has the right to health, and it is crucial to have effective tobacco control and resistance programs and policies. Governments have a duty to protect people's health by preventing the creation of new generations addicted to people-harming products. Given the ongoing and disproportionate impact of tobacco and nicotine-related disease and death—particularly for Indigenous peoples—there is an urgent need for structural change to eradicate these harms and dismantle colonial and commercial systems that sustain them.
- 1 July 2025
- Published by Oxford University Press (OUP) in Health Promotion International
- Vol. 40 (4)
Open AccessColonial harm in new packaging: Indigenous critiques of the tobacco industry's ‘harm reduction’ rhetoric
Over the last 75 years, we have learned that commercial tobacco use causes widespread disease and death. However, the commercial Tobacco and Nicotine Industry continues to promote, market, and sell tobacco and nicotine products to protect and expand profit. This reflects their legal obligation to act in shareholders’ best interests. While the Tobacco and Nicotine Industry heavily promotes alternative products such as electronic cigarettes and nicotine pouches, for now, these represent a relatively small share of profits compared with combustible cigarette sales. The continued reliance on and expansion of these markets generates addiction, dependence, and a range of harms. These actions represent a modern manifestation of colonization—reproducing control and exploitation that affects people at all levels, particularly Indigenous peoples, whose lands, knowledges, and well-being have long been commodified and targeted. The Tobacco and Nicotine Industry and their collaborators employ misleading strategies, including co-opting terms like ‘harm reduction’ and making vague promises about a ‘smoke-free’ or ‘noncombustible’ future. These tactics distract from the continued promotion and sale of harmful products under the guise of public health and harm reduction. This narrative reframes structural and commercial determinants of health as matters of individual choice and enables the continued production of Tobacco and Nicotine Industry–driven harms. Everyone has the right to health, and it is crucial to have effective tobacco control and resistance programs and policies. Governments have a duty to protect people's health by preventing the creation of new generations addicted to people-harming products. Given the ongoing and disproportionate impact of tobacco and nicotine-related disease and death—particularly for Indigenous peoples—there is an urgent need for structural change to eradicate these harms and dismantle colonial and commercial systems that sustain them.
- Open Access
- 13 February 2023
- Published by BMJ in Tobacco Control
- Vol. 33 (e2) , e240-e245
Ethical publishing in ‘Indigenous’ contexts
Ethical publishing practices are vital to tobacco control research practice, particularly research involving Indigenous (Indigenous peoples: For the purposes of this Special Communication, we use the term Indigenous people(s) to include self-identified individuals and communities who frequently have historical continuity with precolonial/presettler societies; are strongly linked to the land on which they or their societies reside; and often maintain their own distinct language(s), belief and social-political systems, economies and sciences. The authors humbly acknowledge, respect and value that Indigenous peoples are diverse and constitute many nations, cultures and language groups. Many Indigenous peoples also exist as governments in treaty relations with settler-colonial societies, and all Indigenous peoples have inherent rights under international law. The language and terminology used should reflect the local context(s) and could include, but are not limited to, terms such as Aboriginal, Bagumani, Cherokee, First Peoples, First Nations, Inuit, Iwaidja, Kungarakan, Lakota, Māori, Mѐtis, American Indian, Navajo, Wagadagam, Wiradjuri, Yurok, etc) people. These practices can minimise, correct and address biases that tend to privilege Euro-Western perspectives. Ethical publishing practices can minimise and address harms, such as appropriation and misuse of knowledges; strengthen mechanisms of accountability to Indigenous peoples and communities; ensure that tobacco control research is beneficial and meaningful to Indigenous peoples and communities; and support Indigenous agency, sovereignty and self-determination. To ensure ethical practice in tobacco control, the research methodology and methods must incorporate tangible mechanisms to include and engage those Indigenous peoples that the research concerns, affects and impacts.Tobacco Controlis currently missing an ethical research and evaluation publishing protocol to help uphold ethical practice. The supporters of this Special Communication call onTobacco Controlto adopt publication practice that explicitly upholds ethical research and evaluation practices, particularly in Indigenous contexts. We encourage researchers, editors, peer reviewers, funding bodies and those publishing inTobacco Controlto reflect on their conduct and decision-making when working, developing and undertaking research and evaluation of relevance to Indigenous peoples.Tobacco Controland other publishers, funding bodies, institutions and research teams have a fundamental role in ensuring that the right peoples are doing the right work in the right way. We call forTobacco Controlto recognise, value and support ethical principles, processes and practices that underpin high-quality, culturally safe and priority-driven research, evaluation and science that will move us to a future that is commercial tobacco and nicotine free.
- 13 February 2023
- Published by BMJ in Tobacco Control
- Vol. 33 (e2) , e240-e245
Open AccessEthical publishing in ‘Indigenous’ contexts
Ethical publishing practices are vital to tobacco control research practice, particularly research involving Indigenous (Indigenous peoples: For the purposes of this Special Communication, we use the term Indigenous people(s) to include self-identified individuals and communities who frequently have historical continuity with precolonial/presettler societies; are strongly linked to the land on which they or their societies reside; and often maintain their own distinct language(s), belief and social-political systems, economies and sciences. The authors humbly acknowledge, respect and value that Indigenous peoples are diverse and constitute many nations, cultures and language groups. Many Indigenous peoples also exist as governments in treaty relations with settler-colonial societies, and all Indigenous peoples have inherent rights under international law. The language and terminology used should reflect the local context(s) and could include, but are not limited to, terms such as Aboriginal, Bagumani, Cherokee, First Peoples, First Nations, Inuit, Iwaidja, Kungarakan, Lakota, Māori, Mѐtis, American Indian, Navajo, Wagadagam, Wiradjuri, Yurok, etc) people. These practices can minimise, correct and address biases that tend to privilege Euro-Western perspectives. Ethical publishing practices can minimise and address harms, such as appropriation and misuse of knowledges; strengthen mechanisms of accountability to Indigenous peoples and communities; ensure that tobacco control research is beneficial and meaningful to Indigenous peoples and communities; and support Indigenous agency, sovereignty and self-determination. To ensure ethical practice in tobacco control, the research methodology and methods must incorporate tangible mechanisms to include and engage those Indigenous peoples that the research concerns, affects and impacts.Tobacco Controlis currently missing an ethical research and evaluation publishing protocol to help uphold ethical practice. The supporters of this Special Communication call onTobacco Controlto adopt publication practice that explicitly upholds ethical research and evaluation practices, particularly in Indigenous contexts. We encourage researchers, editors, peer reviewers, funding bodies and those publishing inTobacco Controlto reflect on their conduct and decision-making when working, developing and undertaking research and evaluation of relevance to Indigenous peoples.Tobacco Controland other publishers, funding bodies, institutions and research teams have a fundamental role in ensuring that the right peoples are doing the right work in the right way. We call forTobacco Controlto recognise, value and support ethical principles, processes and practices that underpin high-quality, culturally safe and priority-driven research, evaluation and science that will move us to a future that is commercial tobacco and nicotine free.
- Open Access
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 348-351
Reflections on Indigenous commercial tobacco control: ‘The dolphins will always take us home’
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 348-351
Open AccessReflections on Indigenous commercial tobacco control: ‘The dolphins will always take us home’